Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Merck & Co. is beginning to pull back the curtain on its R&D strategy under Roger Perlmutter, who left Amgen last year to head Merck’s research operations. The drug company will lessen its traditional focus on in-house research and increasingly look for discoveries made outside its own labs. As such, Merck will establish innovation hubs in Boston, the San Francisco Bay Area, London, and Shanghai as a means of accessing cutting-edge science from academic experts and biotech firms. The news of Merck’s shift was first reported in the Wall Street Journal; Merck confirmed the story’s details but declined to offer further comment.
This article has been sent to the following recipient: